Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-03-26 @ 12:50 PM
Study NCT ID:
NCT03490032
Status:
COMPLETED
Last Update Posted:
2020-11-17
First Post:
2018-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)
Sponsor:
Advanced Accelerator Applications
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer Metastatic | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Prostatic Neoplasms | View |
| None | Cancer of Prostate | View |
| None | Cancer of the Prostate | View |
| None | Neoplasms, Prostate | View |
| None | Prostate Cancer | View |
| None | Prostatic Cancer | View |
| None | Genital Neoplasms, Male | View |
| None | Urogenital Neoplasms | View |
| None | Neoplasms by Site | View |
| None | Neoplasms | View |
| None | Genital Diseases, Male | View |
| None | Prostatic Diseases | View |
| None | PSMA | View |
| None | Prostate-specific membrane antigen | View |
| None | Gallium radioisotope 68 | View |
| None | 68Ga-PSMA-R2 | View |
| None | 68Ga-PSMA ligand | View |